Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-30

Clinical Trial Update: Effect of a Specific Aquaporin-1 Inhibitor on Vascular Oxidative Stress in Healthy Volunteers [NA]

View source ↗

Summary

This completed clinical trial evaluated the effects of a specific Aquaporin-1 inhibitor on vascular oxidative stress in healthy volunteers. Bacopaside II and Ba…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bacopa monnieri
  • Bacopaside II
  • Specific Aquaporin-1 inhibitor

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Oxidative Stress, Cardiovascular Diseases | NA | Status: COMPLETED